No abstract

No abstract

Uma das principais causas de morte e limitação funcional em todo o mundo é o Acidente Vascular Encefálico (AVE), causando alterações significativas sobre as atividades de vida diária do indivíduo. O AVE ocorre a partir de comprometimentos vasculares, ocasionando danos cognitivos e musculares, sendo necessário o tratamento fisioterapêutico para a recuperação da função. A realidade virtual se tornou uma aliada da fisioterapia para a recuperação de pacientes pós-AVE, como forma de tornar o tratamento mais interativo e atraente para o paciente. O presente estudo teve como objetivo verificar a eficácia do uso da realidade virtual na recuperação funcional dos membros superiores em pacientes com sequelas de AVE, por meio de uma revisão sistemática. Os estudos utilizados foram buscados em duas bases de dados, onde aqueles selecionados deveriam obedecer aos critérios de inclusão e exclusão pré-determinados. Os resultados obtidos mostraram que a realidade virtual em conjunto com a fisioterapia pode proporcionar resultados significantes para a melhora funcional do membro superior afetado, o que acarreta melhora e bem-estar geral do paciente.

No abstract

Introduction: The disease SARS-CoV-2, named COVID-19, was officially declared a pandemic by the World Health Organization on March 11 th , 2020. SARS-CoV-2 contains a single-stranded, positive-sense RNA genome surrounded by an extracellular membrane containing a series of spike glycoproteins resembling a crown. Neuropsychiatric manifestations are common during viral pandemics but are not effectively addressed. Case Report: We report the case of a man, 42 years old, who after the infection by SARS-COV2, presented dysnomy, cognitive easing and errors in motor processing. Results and Discussion: Studies have shown the neuroinvasive capability of SARS-COV2, resulting in neurological complications.Common neurological symptoms are headache, dizziness, anosmia, dysgeusia, mental confusion, and muscle weakening, progressing toward severe complications like cerebrovascular disease, seizures, muscle pain, and Guillain-Barre syndrome. The patient in the present case, about seven days after the initial infection, began to have difficulties in naming basic objects and "cognitive" slowness in the performance of basic and instrumental activities of daily life, especially those that required mutual tasks and that required concentration. Patients may be at higher risk of developing cognitive decline after overcoming the primary COVID-19 infection. Neuroinvasive capacities and neuroinflammatory events that may lead to the same short-and long-term neuropathologies that SARS-CoV had shown in human and animal models. The presence of dementia, minimal cognitive impairment and problems with motor planning and execution has been described. Conclusion: A structured prospective evaluation should analyze the likelihood, time course, and severity of cognitive impairment following the COVID-19 pandemic.